| A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05128825) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2022-02-17 |
| Acetazolamide Trial in Normal Pressure Hydrocephalus (NCT04975269) | Uppsala University Hospital | 2022-02-17 |
| JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation (NCT05194995) | Allist Pharmaceuticals, Inc. | 2022-02-17 |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT05032183) | M.D. Anderson Cancer Center | 2022-02-17 |
| Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women (NCT05154578) | Minervax ApS | 2022-02-17 |
| Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) (NCT04707300) | Assistance Publique - Hôpitaux de Paris | 2022-02-16 |
| A Study to Explore the Effect of Sepranolone in Tourette Syndrome (NCT05434546) | Asarina Pharma | 2022-02-16 |
| Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer (NCT05239533) | Memorial Sloan Kettering Cancer Center | 2022-02-16 |
| A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19 (NCT05249829) | ModernaTX, Inc. | 2022-02-16 |
| The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis (NCT05133297) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2022-02-16 |
| Surviving PEA in Roanoke (SPEAR) Study (NCT05283850) | Carol Bernier | 2022-02-16 |
| Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer (NCT05012371) | M.D. Anderson Cancer Center | 2022-02-16 |
| A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure Infections (NCT05339802) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2022-02-16 |
| A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain (NCT05219812) | Bayer | 2022-02-16 |
| Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy (NCT05695456) | Universitaire Ziekenhuizen KU Leuven | 2022-02-16 |
| Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX (NCT06353581) | Yonsei University | 2022-02-16 |
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study (NCT05075980) | Mayo Clinic | 2022-02-16 |
| A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients (NCT05641610) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-16 |
| Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis (NCT05122559) | Emmanuelle Waubant, MD PhD | 2022-02-16 |
| A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia (NCT05214391) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-15 |
| Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD (NCT05885841) | Sinotau Pharmaceutical Group | 2022-02-15 |
| A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer (NCT05141357) | HUYABIO International, LLC. | 2022-02-15 |
| Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation (NCT04651166) | University of Hawaii | 2022-02-15 |
| A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema (NCT05121376) | BioMarin Pharmaceutical | 2022-02-15 |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 (NCT05805956) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-02-15 |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358) | Aadi Bioscience, Inc. | 2022-02-15 |
| Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer (NCT05241340) | The Methodist Hospital Research Institute | 2022-02-15 |
| Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer (NCT05119296) | Stanford University | 2022-02-15 |
| Anakinra for Preterm Infants Pilot (NCT05280340) | Monash Medical Centre | 2022-02-15 |
| Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration (NCT05636566) | Alexandria University | 2022-02-15 |
| A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer (NCT05216237) | Jiuda Zhao | 2022-02-15 |
| P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release (NCT04489134) | Rennes University Hospital | 2022-02-15 |
| Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). (NCT04566133) | National Cancer Institute (NCI) | 2022-02-15 |
| Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV) (NCT05352555) | Stratejik Yenilikci Girisimler Ltd. | 2022-02-15 |
| A Trial of YPEG-rhGH in Children With Short Stature (NCT05838885) | Xiamen Amoytop Biotech Co., Ltd. | 2022-02-15 |
| 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors (NCT04888481) | University of Alberta | 2022-02-15 |
| Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma (NCT05183204) | Weill Medical College of Cornell University | 2022-02-14 |
| Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML (NCT05503134) | Nationwide Children's Hospital | 2022-02-14 |
| Tisleizumab Combined With Lenvatinib and XELOX Regimen (Oxaliplatin Combined With Capecitabine) in the First-line Treatment of Advanced and Unresectable Biliary Tract Tumors (NCT05291052) | The First Affiliated Hospital with Nanjing Medical University | 2022-02-14 |
| A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness (NCT05014672) | Calliditas Therapeutics Suisse SA | 2022-02-14 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) (NCT04897412) | Caliway Biopharmaceuticals Co., Ltd. | 2022-02-14 |
| Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial Disease (NCT05294146) | Radboud University Medical Center | 2022-02-14 |
| Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function (NCT04530383) | University of Kansas Medical Center | 2022-02-14 |
| A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer (NCT05169684) | Bristol-Myers Squibb | 2022-02-14 |
| Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer (NCT05823623) | The First Affiliated Hospital with Nanjing Medical University | 2022-02-13 |
| A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer (NCT05141721) | Seattle Project Corporation | 2022-02-12 |
| Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention (NCT05241431) | University of Aarhus | 2022-02-12 |
| A Study to Evaluate the Efficacy and Safety of AK120 in the Treatment of Subjects With Moderate-to-severe Asthma (NCT05155020) | Akeso | 2022-02-11 |
| Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (NCT05259696) | Palleon Pharmaceuticals, Inc. | 2022-02-11 |
| Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma (NCT04417166) | International Extranodal Lymphoma Study Group (IELSG) | 2022-02-11 |
| A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) (NCT05031780) | Agios Pharmaceuticals, Inc. | 2022-02-11 |
| Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria (NCT04015557) | Hospital de Clinicas de Porto Alegre | 2022-02-11 |
| Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer (NCT05273541) | Beijing 302 Hospital | 2022-02-11 |
| Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer (NCT04984343) | Weill Medical College of Cornell University | 2022-02-11 |
| IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC (NCT05059470) | M.D. Anderson Cancer Center | 2022-02-11 |
| Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma (NCT04998669) | Juan P. Alderuccio, MD | 2022-02-11 |
| EXtending the tIme Window of Thrombolysis by ButyphThalide up to 6 Hours After Onset (EXIT-BT) (NCT05189509) | General Hospital of Shenyang Military Region | 2022-02-11 |
| Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy (NCT05066607) | Intergroupe Francophone du Myelome | 2022-02-11 |
| A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers (NCT05234736) | Caliway Biopharmaceuticals Co., Ltd. | 2022-02-11 |
| Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors (NCT05269316) | Impact Therapeutics, Inc. | 2022-02-11 |
| Study of Copanlisib and Ketogenic Diet (NCT04750941) | Columbia University | 2022-02-10 |
| Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC (NCT05228951) | Shengjing Hospital | 2022-02-10 |
| Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma (NCT05322330) | The First Affiliated Hospital of Soochow University | 2022-02-10 |
| Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients (NCT05155527) | Mahidol University | 2022-02-10 |
| Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC (NCT04925986) | Sarah Goldberg | 2022-02-10 |
| Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong (NCT05254236) | Sinovac Research and Development Co., Ltd. | 2022-02-10 |
| Avatrombopag for Chemotherapy-induced Thrombocytopenia (NCT05218226) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-10 |
| The Effectiveness of a Caralluma Fimbriata Extract on Stress, Sleep and Neurotransmitters (NCT05232266) | RDC Clinical Pty Ltd | 2022-02-10 |
| Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM (NCT05199090) | Novartis Pharmaceuticals | 2022-02-10 |
| Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients (NCT04817241) | National Cancer Institute (NCI) | 2022-02-10 |
| NB-001 in Children and Adolescents With 22q11 Deletion Syndrome (NCT05290493) | Nobias Therapeutics, Inc. | 2022-02-10 |
| Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract (NCT05297760) | University of Zurich | 2022-02-10 |
| Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer (NCT05323201) | The Affiliated Hospital of Xuzhou Medical University | 2022-02-10 |
| A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (NCT05284812) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2022-02-10 |
| Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (NCT04542148) | University of Alabama at Birmingham | 2022-02-10 |
| Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Mild COVID-19 (NCT05783206) | National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia | 2022-02-10 |
| Administration of Fibrinogen Concentrate for Refractory Bleeding (NCT05091684) | Centre Hospitalier Universitaire de Saint Etienne | 2022-02-10 |
| 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients (NCT05141760) | University of Alberta | 2022-02-10 |
| Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma (NCT04955743) | Yale University | 2022-02-09 |
| TReatment for ImmUne Mediated PathopHysiology (NCT04862221) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2022-02-09 |
| Targeting ATR in Soft-tissue Sarcomas (NCT04807816) | Institut Bergonié | 2022-02-09 |
| A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (NCT05118919) | BioGaia Pharma AB | 2022-02-09 |
| Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure (NCT04905810) | Brian Jonas | 2022-02-09 |
| Omega-3 Hydrogel and Prevention of Oral Mucositis (NCT05214495) | Basma Morsy | 2022-02-09 |
| The Effect of Probiotics on Symptoms of Infantile Colic (NCT05198700) | Lallemand Health Solutions | 2022-02-08 |
| An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia (NCT05276830) | BioXcel Therapeutics Inc | 2022-02-08 |
| A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers (NCT05091528) | Silverback Therapeutics | 2022-02-08 |
| Clinical Efficacy of Megadose Vitamin C in Sepsis (NCT05194189) | Zhujiang Hospital | 2022-02-08 |
| A Phase II Trial of Poly-ICLC for Low-Grade Gliomas (NCT04544007) | University of Alabama at Birmingham | 2022-02-08 |
| NTS-WBRT in Brain Metastases (NCT05013892) | Massachusetts General Hospital | 2022-02-08 |
| Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer (NCT04751370) | National Cancer Institute (NCI) | 2022-02-08 |
| NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma (NCT05024318) | Peter MacCallum Cancer Centre, Australia | 2022-02-08 |
| To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2 (NCT05200741) | The University of Hong Kong | 2022-02-08 |
| UNAIR Inactivated COVID-19 Vaccine (NCT05226429) | Dr. Soetomo General Hospital | 2022-02-08 |
| Reconsolidation Therapy With Propranolol as a Treatment for Chronic Pain (NCT05085782) | Université de Sherbrooke | 2022-02-07 |
| Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients (NCT04894123) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2022-02-07 |
| Multi-mode Rehabilitation of Abdominal Tumor Patients Undergoing Concurrent Chemoradiotherapy (NCT05325554) | Zhongnan Hospital | 2022-02-07 |
| A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals (NCT05210101) | Sophia Koo, M.D. | 2022-02-07 |
| Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma (NCT04910347) | Yonsei University | 2022-02-07 |
| Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris (NCT05254249) | Dr. Soetomo General Hospital | 2022-02-07 |